NNM Securities

AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & DrugsHouse : Aurobindo

BSE1087.10-27.8 (-2.49 %)

PREV CLOSE ( ) 1114.90

OPEN PRICE ( ) 1100.40

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 75136

TODAY'S LOW / HIGH ( )1079.00 1104.20

52 WK LOW / HIGH ( )575.1 1177

NSE1087.05-27.45 (-2.46 %)

PREV CLOSE( ) 1114.50

OPEN PRICE ( ) 1109.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1087.05 (1075)

VOLUME 1304443

TODAY'S LOW / HIGH( ) 1079.00 1109.00

52 WK LOW / HIGH ( )576.15 1177.1

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 26-12 1986

Management Info

- Chairman K Nithyananda Reddy - Managing Director

Registered Office

Address Plot No. 2,Maitrivihar ,Ameerpet,
Hyderabad,
Telangana-500038

Phone 040-23736370 / 23747340

Email info@aurobindo.com

Website www.aurobindo.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE, MCX

NEWS

08Apr Aurobindo Pharma informs about issuanc
Pursuant to Regulation 39(3) of the Securities and Exchange Board of Ind..

05Apr Aurobindo Pharma informs about disclos
Aurobindo Pharma has confirmed that the Company is not falling under the..

05Apr USFDA concludes inspection at Andhra P
The United States Food and Drug Administration (USFDA) has concluded the..

03Apr Aurobindo Pharma informs about disclos
Aurobindo Pharma has informed that the exchange has received the disclos..

20Mar Aurobindo Pharma gets final nod to man
Aurobindo Pharma has received final approval from the US Food & Drug..

Financials

Rs. in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	6237.8	12304.1
Gross Profit	6872.2	16143.5
Operating Profit	8128.2	21646.8
Net Sales	26920.3	127922.8

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Bharat Parenterals (BSE) 1455.20 (10.00%)	M.Cap (Rs. in Cr)846.88
Solara Active Pharma (BSE) 551.45 (16.32%)	M.Cap (Rs. in Cr)1985.01
Abbott India (BSE) 26131.85 (0.29%)	M.Cap (Rs. in Cr)55528.36
Windlas Biotech (BSE) 555.05 (6.97%)	M.Cap (Rs. in Cr)1154.42
Concord Biotech (BSE) 1595.25 (1.05%)	M.Cap (Rs. in Cr)16688.90

Shareholding Pattern

	PROMOTERS	51.83%
	MUTUAL FUNDS/UTI	17.83%
	NON-INSTITUTION	6.87%
	FI/BANKS/INSURANCE	5.03%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Tata India Pharma &...	8.87
Mirae Asset Healthc...	8.25
Quant Mid Cap Fund(G)	6.94
ICICI Pru Pharma He...	6.56
Quant Large & Mid C...	5.25
Quant ELSS Tax Save...	4.79
Tata Equity Savings...	4.79

ATTENTION INVESTORSKYCIPO

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :

Assamese	Bengali	Gujrati	Hindi	Kanada
Kashmiri	Konkani	Malyalam	Marathi	Oriya
Punjabi	Sindhi	Tamil	Telegu	Urdu

REGISTRATION NOS.

Filing compliant on SCORES – Easy & quick

Register on SCORES portal
Mandatory details for filing complaints on SCORES:
- Name
- PAN
- Address
- Mobile Number
- E-mail ID
Benefits:
- i.) Effective communication
- ii.) Speedy redressal of the grievances

SMART ODR Portal

INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

NNM Securities

Smart Quotes

AUROBINDO PHARMA LTD.

Filing compliant on SCORES – Easy & quick